A comparison of proliferation markers and their prognostic value for women with endothelial carcinoma: Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction

Cancer

Volumn 78, Issue 9, 1996, Pages 1942-1951

  Nordström, Britta ^a   Strang, Peter ^a   Bergström, Reinhold ^b   Nilsson, Sten ^a   Tribukait, Bernhard ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

endometrial carcinoma; Ki 67; prognosis; proliferating cell nuclear antigen; proliferation; S phase fraction

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67; TUMOR MARKER;

ADULT; ARTICLE; CANCER SURVIVAL; CELL CYCLE S PHASE; ENDOMETRIUM CARCINOMA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; PLOIDIES; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSPECTIVE STUDIES; S PHASE;

EID: 0029831211     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961101)78:9<1942::AID-CNCR15>3.0.CO;2-Y     Document Type: Article

References (48)

1. Stendahl U, Strang P, Wagenius G, Bergström R, Tribukit B. Prognostic significance of proliferation in endometrial carcinoma: a multivariate analysis of clinical and flow cytometric variables. Int J Gynecol Pathol 1991;10:271-84.
2. Wagenius G, Bergström R, Strang P, Gredes U, Rogo K, Tribukait B, et al. Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II. Anticancer Res 1991;11:2137-42.
3. Friberg L-G, Norén H, Delle U. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study. Gynecol Oncol 1994;53:64-9.
4. Strang P, Stenkvist B, Bergström R, Stendahl U, Valdes del Campo M, Tribukait B. Flow cytometry and interactive image cytometry in endometrial carcinoma: a comparative and prognostic study. Anticancer Res 1991;11:783-88.
5. Rosenberg P, Wingren S, Simonsen E, Stål O, Risberg B, Nordenskjöld B. Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: an important prognostic indicator. Gynecol Oncol 1989;35:50-4.
6. Gudmundsson TE, Högberg T, Alm P, Anderson, Baldetorp B, Fernö M, et al. The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma. Acta Oncol 1995;34:803-12.
7. He Q, Skog S, Wang N, Eriksson S, Tribukait B. Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. Eur J Cell Biol. In press.
8. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982;218:474-5.
9. Gray JW, Mayal BH. Monoclonal antibody against bromodeoxyuridine. New York: Alan R Liss, Inc, 1985.
10. Nielsen AL, Nyholm HC, Engel P. Expression of MIB-1 (paraffin Ki-67) and AgNOR morphology in endometrial adenocarcinomas of endometroid type. Int J Gynecol Pathol 1994;13:37-44.
11. Begg AC, McNally NJ, Shrieve SG. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985;6:620-6.
12. Gerdes J, Li L, Schloeter C, Duchrow H, Wohlenberg, Gerlach C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-73.
13. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
14. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
15. Sasaki K, Murakami T, Kawasaki M, Takahashi M. The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J Cell Physiol 1987;133:579-84.
16. Bravo R, Frank R, Blundell PA, MacDonald-Bravo H. Cyclin PCNA is the auxiliary protein of DNA polymerase δ. Nature 1987a;326:515-7.
17. Wada T, Shimabukuro T, Matsuyama H, Naito K, Skog S, Tribukait B. Optimal condition of fixation for immunohistochemical staining of proliferating cell nuclear antigen in tumor cells and its cell cycle related immunohistochemical expression. Cell Prolif 1994;27:541-51.
18. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology (invited review). Histopathology 1990; 17:489-503.
19. Hall PA, Levison DA. Assessment of cell proliferation in histological material [review]. J Clin Pathol 1990;43:184-92.
20. Bush C, Price P, Norton J, Parkins CS, Bailey MJ, Boyd J, et al. Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance. Br J Cancer 1991;64:357-60.
21. Mulder AH, van Hootegem CSP, Sylvester R, Ten Kate FJW, Kurth KH, Ooms ECM, et al. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67). J Pathol 1992;166:37-43.
22. Cohen MB, Waldman FM, Carroll P, Kerschmann R, Chew K, Mayall BH. Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder. Hum Pathol 1993;24:772-8.
23. Henriksen R, Strang P, Bäckström T, Wilander E, Tribukait B, Öberg K. Ki-67 immunostaining and DNA flow cytometry as prognostic factors in epithelial ovarian cancers. Anticancer Res 1994;14:603-8.
24. Kawai T, Suzuki M, Kono S, Shinomiya N, Rokutanda M, Takagi K, et al. Proliferating Cell Nuclear Antigen and Ki-67 in lung carcinoma. Correlation with DNA Flow Cytometric Analysis. Cancer 1994;74:2468-75.
25. Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-94.
26. Kamel OW, Lebrun DP, Davis RE, Berry GJ, Warnke RA. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/ Cyclin 19A2. Am J Pathol 1991;138:1471-7.
27. Lipponen PK, Eskelinen MJ. Cell proliferation of transitional cell bladder tumors determined by PCNA/cyclin immunostaining and its prognostic value. Br J Cancer 1992;66:171-6.
28. 2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology 1991;19:21-7.
29. Lam K-Y, Law S, Ka-Pui So M, Fok M, Tung Ma L, Wong J. Prognostic implication of proliferative markers MIB-1 and PC 10 in esophageal squamous cell carcinoma. Cancer 1996;77:7-13.
30. FIGO stages - 1988 revisions: vulva, ovary, corpus. Gynecol Oncol 1989;35:125-7.
31. Poulsen H, Taylor CW, Sobin LH. Histological typing of female genital tract tumors. In: International histologic classification of tumors. Geneva: World Health Organization, 1975;13:63-73.
32. Kjellgren O, Jonsson L. Further development of the Heyman radium packing method. Acta Radiol 1964;3:143-51.
33. Tribukait B. Flow cytometry in surgical pathology and cytology of tumors of the genito-urinary tract. In: Koss LG, Coleman D, editors. Advances in clinical cytology. Volume 2. New York: Masson, 1984;163-89.
34. Heiden T, Strang P, Stendahl U, Tribukait B. Reproducibility of flow cytometric analyses in human malignancies. Anticancer Res 1990;10:49-54.
35. Castro J, Heiden T, Wang N, Tribukait B. Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry 1993;14:7938-40.
36. Baisch H, Göhde W, Linden W. Analysis of PCP-data to determine the fraction of cells in various phases of cell cycle. Radiat Environ Biophys 1975;12:31-7.
37. Lawless JF. Statistical models and methods for life-time data. New York: Wiley, 1982.
38. Celis J, Madsen P. Increased nuclear cyclin/PCNA antigen staining of non-S phase transformed human amnion cells engaged in nucleotide excision DNA repair. FEBS Lett 1986;209:277-83.
39. Toschi L, Bravo R. Changes in cyclin/PCNA distribution during DNA repair synthesis. J Cell Biol 1988;107:1623-8.
40. Khalifa MA, Mannel RS, Haraway SD, Walker J, Min K-W. Expression of EGFR, HER-2/neu, p53, and PCNA in endometroid, serous papillary, and clear cell endometrial adenocarcinomas. Gynecol Oncol 1994;53:84-92.
41. Zuber P, Hamou M-F, de Trinbolet N. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. Neurosurgery 1988;22:364-8.
42. Walker RA, Camplejohn RS. Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas. Br J Cancer 1988;57:281-3.
43. Ueda T, Aozasa K, Tsujimoto M, Ohsawa M, Uchida A, Aoki Y, et al. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 1989;63:1607-11.
44. Braun N, Papadopoulos T, Muller-Hermelink HK. Cell cycle dependent distribution of the proliferation-associated Ki-67 antigen in human embryonic lung cells. Virchows Archiv. Cell Pathol 1988;56:25-33.
45. Cattoretti G, Becker MHG, Key G, Duchrow M, Schüler C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
46. Nielsen AL, Nyholm HC. Proliferating activity as revealed by Ki-67 in uterine adenocarcinoma of endometrioid type: comparison of tumour from patients with and without previous oestrogen therapy. J Pathol 1993;171:199-205.
47. Charpin C, Andrac L, Habib M, Vacheret H, Lavaut MN, Xerri L, et al. Immunocytochemical assays in human endometrial carcinomas: a multiparametric computerized analysis and comparison with nonmalignant changes. Gynecol Oncol 1989;33:9-22.
48. Verheijen R, Kuijpers HJH, van Driel R, Beck JLM, van Dierendonck JH, Barkenhoff GJ, et al. Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localization in mitotic cells and association with chromosomes. J Cell Sci 1989;92:531-40.